China Pharma Holdings (CPHI) Swings to Q3 Loss

China Pharma Holdings (NYSE: CPHI) reported Q3 EPS of ($0.04), versus $0.07 reported last year. Revenue for the quarter came in at $3.1 million, versus $4.5 million reported last year.

For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c